HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lumbar Sympathetic Block with Botulinum Toxin Type B for Complex Regional Pain Syndrome: A Case Study.

Abstract
Lumbar sympathetic block (LSB) is an effective method for relief of sympathetically mediated pain in the lower extremities. To prolong the sympathetic blockade, sympathetic destruction with alcohol or radiofrequency has been used. The pre-ganglionic sympathetic nerves are cholinergic, and botulinum toxin (BTX) has been found to inhibit the release of acetylcholine at the cholinergic nerve terminals. Moreover, BTX type B (BTX-B) is more convenient to use than BTX type A. Based on these findings, we performed LSB on the 2 patients with complex regional pain syndrome (CRPS) in the lower extremity. Levobupivacaine 0.25% 5 mL mixed with BTX-B 5,000 IU was given under fluoroscopic guidance. Two months after LSB with BTX-B, pain intensity and the Leeds assessment of neuropathic symptoms and signs (LANSS) score were significantly reduced. Allodynia and coldness disappeared and skin color came back to normal. In conclusion, BTX-B can produce an efficacious and durable sympathetic blocking effect on patients with CRPS.
AuthorsEunjoo Choi, Chan Woo Cho, Hye Young Kim, Pyung Bok Lee, Francis Sahngun Nahm
JournalPain physician (Pain Physician) 2015 Sep-Oct Vol. 18 Issue 5 Pg. E911-6 ISSN: 2150-1149 [Electronic] United States
PMID26431145 (Publication Type: Journal Article)
Chemical References
  • Anesthetics, Local
  • Neuromuscular Agents
  • Sympatholytics
  • Levobupivacaine
  • Botulinum Toxins, Type A
  • Bupivacaine
Topics
  • Anesthetics, Local (administration & dosage, therapeutic use)
  • Ankle
  • Autonomic Nerve Block (methods)
  • Botulinum Toxins, Type A (therapeutic use)
  • Bupivacaine (administration & dosage, analogs & derivatives, therapeutic use)
  • Complex Regional Pain Syndromes (drug therapy)
  • Humans
  • Hyperalgesia (drug therapy, etiology)
  • Leg
  • Levobupivacaine
  • Lower Extremity
  • Male
  • Neuralgia (drug therapy)
  • Neuromuscular Agents (therapeutic use)
  • Skin Pigmentation (drug effects)
  • Sympathectomy, Chemical (methods)
  • Sympatholytics (therapeutic use)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: